Dr. Betsy Garofalo has been named as the global therapy area leader for CNS, Astellas Pharma Global Development. Dr. Garofalo is a pediatric neurologist and epileptologist and has more than 17 years of drug development experience.
"Betsy's charge as head of the global therapy area is to provide strategic direction and leadership for the development of all Astellas CNS compounds," said Dr. Steven Ryder, president of APGD. Betsy's deep experience in CNS disorders and past successes make her an excellent choice to help us develop new medications for the many patients with unmet medical needs.
In addition to her work at Astellas, Dr. Garofalo is an adjunct associate professor of pediatrics at the University of Michigan. In 2007, she formed the Michigan Technology and Research Institute, where she provided consulting services to the pharmaceutical industry. Dr. Garofalo previously held numerous positions of leadership at Parke-Davis and Pfizer R&D.